about
Microbiology laboratory and the management of mother-child varicella-zoster virus infectionVaricella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3Impact of varicella vaccine on varicella-zoster virus dynamicsCD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled studyA phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.Varicella immunity in Iran: an age-stratified systematic review and meta-analysis.Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.Attenuation of the adaptive immune response in rhesus macaques infected with simian varicella virus lacking open reading frame 61.Genome-wide analysis of T cell responses during acute and latent simian varicella virus infections in rhesus macaquesSuppressor of Cytokine Signaling 3 Expression Induced by Varicella-Zoster Virus Infection Results in the Modulation of Virus Replication.Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry.Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.Varicella zoster viraemia during herpes zoster is not associated with neoplasia.Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy.Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs.
P2860
Q26738745-F52BA37F-F80C-4457-9048-B273454D098AQ28743826-2B8E0600-2C4C-4ECF-A259-5751F69BAB25Q33591264-92EB7A53-BF10-4FC0-B727-73E57F62489BQ34079162-3EB193DA-8DA9-4DCD-B2B4-006F57E3C65CQ34390072-555AB1ED-7CF3-4295-8EB9-CBBF220559EEQ34446365-34B68229-80EF-4016-AC1F-16445E413887Q35081168-5F86F3C3-7602-4305-8BF2-F77AED9F4354Q35133349-77D8BBB8-E4FF-48AD-9ADC-18CCB8E55E5AQ35543651-EB783054-8450-4257-9161-97A3A44FF7A3Q35852348-D8CAAEC5-FF2B-4F2F-83FA-A6B1FA403D77Q36607327-CF662965-425C-4450-BB35-C95717B52AD6Q37252780-FF55B2FE-BEF2-49EA-9A2E-809ED9C882F1Q38864276-FAC0C81A-FC77-4B1A-9816-4A971BFC8480Q39886036-092B93EA-4251-4381-900E-FB89F029BF2EQ42242630-803644A4-DFFE-4961-AD21-F965F80EDA63Q44133002-8DAF1D30-CF1C-430F-9303-B5446669E580Q45355413-47AEB3DE-919C-4AA7-A891-CF2256239867Q45357500-D4D400E4-8E69-4F04-80FB-E031F4498043Q46031180-FF1AAF22-3713-4205-87D6-86C2774A7781
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Immune responses to varicella-zoster virus.
@en
type
label
Immune responses to varicella-zoster virus.
@en
prefLabel
Immune responses to varicella-zoster virus.
@en
P1476
Immune responses to varicella-zoster virus.
@en
P2093
P304
P356
10.1016/S0891-5520(05)70312-3
P577
1996-09-01T00:00:00Z